Gilead stock rises on more upbeat forecasts, while COVID drug sales slide
October 27, 2022 at 16:26 PM EDT
Shares of Gilead Sciences Inc. rose after the drugmaker reported third-quarter results that topped expectations and boosted its full-year profit and sales outlook.
